Ignite Creation Date:
2024-05-06 @ 1:27 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04029428
Status:
UNKNOWN
Last Update Posted:
2020-04-01
First Post:
2019-05-19
Brief Title:
Peptide Receptor Radionuclide Therapy in the Treatment of Advanced Non-resectable andor Symptomatic Tumors With SSTR Overexpression
Sponsor:
University of Warmia and Mazury
Organization:
University of Warmia and Mazury
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neuroendocrine Tumors |
Keywords:
| Name | View |
|---|---|
| PFS - progression free survival | View |
| PRRT - Peptide Receptor Radionuclide Therapy | View |
| GEP-NET - Gastro-Entero-Pancreatic Neuroendocrine Tumours | View |
| BPCs - Bronchopulmonary Carcinoids Atypical Typical | View |
| PPGLs - PheochromocytomasParagangliomas | View |
| NET-CUP - Neuroendocrine Tumours of unknown primary | View |
| clinical efficacy | View |
| toxcity - adverse events AEs | View |
| OS - overall survival | View |